Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
1.410
+0.040 (2.92%)
At close: Apr 17, 2025, 4:00 PM
1.370
-0.040 (-2.84%)
After-hours: Apr 17, 2025, 6:35 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $3.73 million as of April 17, 2025. Its market cap has decreased by -50.03% in one year.
Market Cap
3.73M
Enterprise Value
-3.19M
1-Year Change
-50.03%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $3.73M, a decrease of -94.28%. That is a compound annual growth rate of -54.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 3.73M | -6.42% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |